MetLife: A Great Time To Buy The Preferred Stock

MetLife preferred shares are highlighted as offering a 6.15% yield at about $19.25, supported by a very low payout ratio of under 4% of adjusted earnings that could fall to 3% as EPS grows. The article argues rising rates have pressured preferred prices, creating an attractive risk/reward setup for long-term investors. Strong balance sheet coverage is cited as support for continued preferred dividend payments.

Analysis

This is less a “safe yield” story than a relative-value dislocation created by rates moving faster than credit fundamentals. The equity market is pricing the preferred like a duration asset, but the issuer’s real risk driver is not rate sensitivity alone; it is whether the common dividend, capital generation, or regulation changes the seniority stack. With payout coverage this deep, the preferred behaves more like a long-duration investment-grade spread product than a distressed financial security, so incremental widening should be limited unless spreads blow out broadly across insurers.

The second-order beneficiary is the broader insurance preferred complex: if MET’s paper can clear 6% with strong coverage, other high-quality financial preferreds likely re-rate as investors search for yield without moving further down the credit ladder. That creates a catch-up trade in peers with similar balance-sheet strength but wider preferred discounts, while more levered issuers should lag as investors become more discriminating about coverage rather than headline coupon. For common equity holders, there is little direct upside from the preferred’s cheapness, but the existence of attractively priced preferred capital gives the firm optionality to preserve common dividend flexibility in a downturn.

The key risk is not near-term dividend suspension; it is mark-to-market pain if real yields stay elevated for another 2-3 quarters or if insurers’ credit spreads widen in a recession scare. In that scenario, the preferred can drift lower even if fundamentals remain intact, and the buyer must be patient. The contrarian view is that the market may be over-anchored to rate pressure and underweight the fact that the spread over Treasuries is already compensating for most credit risk; if rates stabilize, the paper can re-rate quickly toward par over a 6-12 month horizon.

Key Decisions for Investors

• Buy MET.PR.F on weakness below current levels for a 6-12 month hold; target a move back toward par with limited fundamental downside unless insurer spreads materially widen.
• Pair trade: long MET preferred vs short a lower-quality financial preferred basket over 3-6 months to isolate credit quality from rate duration.
• If rates continue grinding higher over the next 1-2 quarters, use put protection or stop-losses rather than selling outright; this is a spread product, not a catalyst-driven momentum trade.
• Rotate into similar high-quality financial preferreds trading at wider discounts; MET.PR.F is the benchmark for valuation, not necessarily the best entry point on an absolute basis.
• Monitor insurer CDS and broader financial spread indices as the real catalyst set; if spreads tighten while rates stabilize, add aggressively, but if recession risk pushes spreads wider, reduce exposure quickly.